Managers / Q3 2019 · view latest →
TANAKA CAPITAL MANAGEMENT INC
CIK 0000816788 · 60 EAST 42ND STREET, SUITE 4000, NEW YORK, NY, 10165 · 2124903380
Summary
Tanaka Capital Management Inc reported $31M in U.S.-listed holdings across 51 positions for Q3 2019.
Its largest position, Amyris, represents 14.3% of the portfolio.
Compared with Q2 2019, the fund opened 0 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 73.8% · $23M
- Other · 26.1% · $8M
- ADR · 0.1% · $32,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Neurotrope | SOLD OUT | −189.0K | 0 | −$2M | $0 |
| ProMetic Life Sciences | TRIMMED | −23.3K | 22 | +$0 | $0 |
| MDLZMondelez International, Inc. | TRIMMED | −160 | 302 | −$8,000 | $17,000 |
| CN2Catalyst Pharmaceuticals | ADDED | +57.8K | 283.3K | +$639,000 | $2M |
| NXENexGen Energy | TRIMMED | −294.8K | 871.7K | −$698,000 | $1M |
| QCOMQUALCOMM | TRIMMED | −4.0K | 20.7K | −$297,000 | $2M |
| Kraft Heinz Company | TRIMMED | −53 | 279 | −$2,000 | $8,000 |
| Carrizo Oil and Gas | TRIMMED | −4.5K | 23.7K | −$79,000 | $204,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $60M | 44 | May 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $55M | 45 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $56M | 45 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $42M | 42 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $44M | 44 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $43M | 45 | Nov 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $42M | 47 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $41M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $41M | 49 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $35M | 47 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $37M | 48 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $34M | 49 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $32M | 48 | Feb 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $34M | 48 | Nov 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $31M | 48 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $50M | 53 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $53M | 53 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $70M | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $74M | 55 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $79M | 51 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $45M | 51 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $32M | 53 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $32M | 53 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $23M | 51 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $32M | 51 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $31M | 51 | Nov 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $33M | 52 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $33M | 54 | May 16, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.